This page is part of the HL7 FHIR Implementation Guide: minimal Common Oncology Data Elements (mCODE) Release 1 - US Realm | STU1 (v2.1.0: STU 2) based on FHIR R4. This is the current published version in its permanent home (it will always be available at this URL). For a full list of available versions, see the Directory of published versions
Active as of 2023-03-21 |
<ValueSet xmlns="http://hl7.org/fhir">
<id value="mcode-histology-morphology-behavior-vs"/>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><p>This value set includes codes based on the following rules:</p><ul><li>Include all codes defined in <a href="http://terminology.hl7.org/5.0.0/CodeSystem-icd-o-3.html"><code>http://terminology.hl7.org/CodeSystem/icd-o-3</code></a></li><li>Include codes from <a href="http://www.snomed.org/"><code>http://snomed.info/sct</code></a> where concept is-a 367651003 (Malignant Neoplasm (Morphology))</li><li>Include codes from <a href="http://www.snomed.org/"><code>http://snomed.info/sct</code></a> where concept is-a 399919001 (Carcinoma in situ - category (morphologic abnormality))</li><li>Include codes from <a href="http://www.snomed.org/"><code>http://snomed.info/sct</code></a> where concept is-a 399983006 (In situ adenomatous neoplasm - category (morphologic abnormality))</li><li>Include these codes as defined in <a href="http://www.snomed.org/"><code>http://snomed.info/sct</code></a><table class="none"><tr><td style="white-space:nowrap"><b>Code</b></td><td><b>Display</b></td></tr><tr><td><a href="http://snomed.info/id/399878004">399878004</a></td><td>Malignant neoplasm with pilar differentiation (morphologic abnormality)</td></tr><tr><td><a href="http://snomed.info/id/253035009">253035009</a></td><td>In situ melanocytic morphology (morphologic abnormality)</td></tr></table></li></ul><p>This value set excludes codes based on the following rules:</p><ul><li>Exclude codes from <a href="http://www.snomed.org/"><code>http://snomed.info/sct</code></a> where concept is-a 450893003 (Papillary neoplasm, pancreatobiliary-type, with high grade intraepithelial neoplasia (morphologic abnormality))</li><li>Exclude codes from <a href="http://www.snomed.org/"><code>http://snomed.info/sct</code></a> where concept is-a 128640002 (Prostatic intraepithelial neoplasia, grade III)</li><li>Exclude codes from <a href="http://www.snomed.org/"><code>http://snomed.info/sct</code></a> where concept is-a 450890000 (Glandular intraepithelial neoplasia, low grade)</li><li>Exclude codes from <a href="http://www.snomed.org/"><code>http://snomed.info/sct</code></a> where concept is-a 703548001 (Atypical hyperplasia of the endometrium)</li></ul></div>
</text>
<url
value="http://hl7.org/fhir/us/mcode/ValueSet/mcode-histology-morphology-behavior-vs"/>
<version value="2.1.0"/>
<name value="HistologyMorphologyBehaviorVS"/>
<title value="Histology Morphology Behavior Value Set"/>
<status value="active"/>
<experimental value="false"/>
<date value="2023-03-21T04:50:14+11:00"/>
<publisher value="HL7 International Clinical Interoperability Council"/>
<contact>
<name value="HL7 International Clinical Interoperability Council"/>
<telecom>
<system value="url"/>
<value value="http://www.hl7.org/Special/committees/cic"/>
</telecom>
<telecom>
<system value="email"/>
<value value="ciclist@lists.HL7.org"/>
</telecom>
</contact>
<description
value="Codes representing the structure, arrangement, and behavioral characteristics of malignant neoplasms, and cancer cells. Inclusion criteria: in situ neoplasms and malignant neoplasms. Exclusion criteria: benign neoplasms and neoplasms of unspecified behavior. Note: ICD-O-3 morphology codes are referenced in the logical definition but not expanded in the value set for intellectual property reasons. For primary cancers, the ICD-O-3 behavior suffix should be /1, /2, or /3. For secondary cancers, the ICD-O-3 behavior suffix should be /6."/>
<jurisdiction>
<coding>
<system value="urn:iso:std:iso:3166"/>
<code value="US"/>
<display value="United States of America"/>
</coding>
</jurisdiction>
<copyright
value="This value set includes content from SNOMED CT, which is copyright © 2002+ International Health Terminology Standards Development Organisation (IHTSDO), and distributed by agreement between IHTSDO and HL7. Implementer use of SNOMED CT is not covered by this agreement"/>
<compose>
<include>
<system value="http://terminology.hl7.org/CodeSystem/icd-o-3"/>
</include>
<include>
<system value="http://snomed.info/sct"/>
<filter>
<property value="concept"/>
<op value="is-a"/>
<value value="367651003"/>
</filter>
</include>
<include>
<system value="http://snomed.info/sct"/>
<filter>
<property value="concept"/>
<op value="is-a"/>
<value value="399919001"/>
</filter>
</include>
<include>
<system value="http://snomed.info/sct"/>
<filter>
<property value="concept"/>
<op value="is-a"/>
<value value="399983006"/>
</filter>
</include>
<include>
<system value="http://snomed.info/sct"/>
<concept>
<code value="399878004"/>
<display
value="Malignant neoplasm with pilar differentiation (morphologic abnormality)"/>
</concept>
<concept>
<code value="253035009"/>
<display
value="In situ melanocytic morphology (morphologic abnormality)"/>
</concept>
</include>
<exclude>
<system value="http://snomed.info/sct"/>
<filter>
<property value="concept"/>
<op value="is-a"/>
<value value="450893003"/>
</filter>
</exclude>
<exclude>
<system value="http://snomed.info/sct"/>
<filter>
<property value="concept"/>
<op value="is-a"/>
<value value="128640002"/>
</filter>
</exclude>
<exclude>
<system value="http://snomed.info/sct"/>
<filter>
<property value="concept"/>
<op value="is-a"/>
<value value="450890000"/>
</filter>
</exclude>
<exclude>
<system value="http://snomed.info/sct"/>
<filter>
<property value="concept"/>
<op value="is-a"/>
<value value="703548001"/>
</filter>
</exclude>
</compose>
</ValueSet>
IG © 2022+ HL7 International Clinical Interoperability Council. Package hl7.fhir.us.mcode#2.1.0 based on FHIR 4.0.1. Generated 2023-03-21
Links: Table of Contents |
QA Report
| Version History |
|
Propose a change